The authors discuss the two opposite roles of residential mesenchymal stem cells (MSCs) and external MSCs in fibrotic diseases, and summarize the current perspective of therapeutic mechanism of MSCs in fibrosis, through both laboratory study and clinical trials.
[Acta Pharmacologica Sinica]
